Statistical analysis based on online databases such as TCGA and International Cancer Genome Consortium (ICGC) 7, 10, 12, 34 suggests that SPC25 expression is closely related to poor prognosis in patients with HCC, non-small cell lung adenocarcinoma cells, and prostate cancer. Here, SPC25 is linked to prostate cancer.